Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
CALL
WIX.com
WIX
$2.78B
| $242K | ﹤0.01% |
+2,400
| New | +$313K |
|
|
CBIO
3252
Crescent Biopharma
CBIO
$592M
| $241K | ﹤0.01% |
1,058
+276
| +35% | +$105K |
|
3253
Tilray
TLRY
$598M
| $241K | ﹤0.01% |
3,509
-561
| -14% | -$78.3K |
|
|
NPKI
3254
NPK International
NPKI
$1.16B
| $241K | ﹤0.01% |
269,133
-60,303
| -18% | -$226K |
|
3255
PUT
Allstate
ALL
$67.8B
| $238K | ﹤0.01% |
+2,600
| New | +$283K |
|
3256
Vanguard Long-Term Bond ETF
BLV
$5.76B
| $237K | ﹤0.01% |
2,221
-3,219
| -59% | -$336K |
|
3257
Larimar Therapeutics
LRMR
$433M
| $237K | ﹤0.01% |
25,658
-4,964
| -16% | -$65.3K |
|
3258
PUT
uniQure
QURE
$3.05B
| $237K | ﹤0.01% |
5,000
| – | – |
|
3259
NRC Health Common Stock
NRC
$433M
| $236K | ﹤0.01% |
5,189
-38
| -0.7% | -$2.28K |
|
3260
iShares Russell 2000 ETF
IWM
$82.9B
| $235K | ﹤0.01% |
2,056
-704,553
| -100% | -$105M |
|
3261
National Grid
NGG
$80.5B
| $235K | ﹤0.01% |
4,567
-106,506
| -96% | -$5.88M |
|
3262
Northrim BanCorp
NRIM
$602M
| $235K | ﹤0.01% |
34,844
-65,712
| -65% | -$566K |
|
|
BRQS
3263
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
| $235K | ﹤0.01% |
1,103
-1
| -0.1% | -$287 |
|
|
SOLN
3264
DELISTED
The Southern Company
SOLN
| $233K | ﹤0.01% |
5,249
-9,295
| -64% | -$487K |
|
3265
Black Diamond Therapeutics
BDTX
$103M
| $232K | ﹤0.01% |
+9,296
| New | +$283K |
|
3266
CALL
GDS Holdings
GDS
$6.61B
| $232K | ﹤0.01% |
4,000
-1,600
| -29% | -$89.2K |
|
3267
REX American Resources
REX
$1.46B
| $232K | ﹤0.01% |
29,946
-11,016
| -27% | -$125K |
|
3268
CALL
RH
RH
$3.7B
| $231K | ﹤0.01% |
+2,300
| New | +$429K |
|
|
PENG
3269
Penguin Solutions Inc
PENG
$2.93B
| $231K | ﹤0.01% |
18,992
-426,550
| -96% | -$6.24M |
|
|
RBNC
3270
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $231K | ﹤0.01% |
+20,465
| New | +$393K |
|
3271
CALL
Energy Transfer Partners
ET
$70.2B
| $230K | ﹤0.01% |
50,000
-160,000
| -76% | -$1.7M |
|
|
SAVE
3272
DELISTED
Spirit Airlines, Inc.
SAVE
| $230K | ﹤0.01% |
17,882
-982,042
| -98% | -$31.6M |
|
3273
Anterix
ATEX
$1.9B
| $229K | ﹤0.01% |
+5,013
| New | +$227K |
|
3274
CALL
AB InBev
BUD
$168B
| $229K | ﹤0.01% |
+5,200
| New | +$339K |
|
3275
Danaos Corp
DAC
$2.5B
| $229K | ﹤0.01% |
57,373
-73,417
| -56% | -$449K |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.